COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Retinal Imaging Devices Market would witness market growth of 6.2% CAGR during the forecast period (2019-2025).
The fundus camera provides this device with various advantages, such as portability and ergonomics. Additionally, the growing number of fundus cameras installations with an increased number of ophthalmic clinics and outpatient eye care centers is estimated to drive market growth. Optical coherence tomography (OCT) is equivalent to a histopathological portion of tissue. One can examine individual retinal cell layers and pathological lesions within them. OCT detects a subtle pathology that often goes overlooked during a clinical exam. An OCT device is used on an undilated pupil. Despite the density of cataracts, modern OCT machines can capture images of good quality. The recent addition of OCT angiography allows for dyeless visualization in the macula of retinal vessels.
In the end-use segment, the ambulatory surgery centers (ASCs) sub-segment has been anticipated to grow at the highest growth rate over the forecast period. The growth of the segment is expected to be driven by effective reimbursement policies by Medicare for vitreoretinal surgery in these centers. Hospitals retained the largest market share of retinal imaging products in 2018 due to the high demand for technologically advanced solutions.
Europe is a significant market for ophthalmic devices due to an increased incidence of chronic eye diseases among the aging population. For example, 34 million people in the European Union suffered from age-related macular degeneration (AMD) in 2017; this pool of patients is expected to grow by around 25 percent before 2050.
Based on Type, the market is segmented into Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography). Based on End Use, the market is segmented into Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.
Scope of the Study
Market Segmentation:
By Type

  • Fundus Camera
  • Fluorescein Angiography
  • OCT (Optical Coherence Tomography)


By End Use

  • Hospitals
  • Ophthalmic Centers
  • ASCs (Ambulatory Surgery Centers)
  • Other End Use


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Topcon Corporation
  • Carl Zeiss AG
  • Olympus Corporation
  • Robert Bosch GmbH (Bosch Healthcare)
  • Revenio Group Oyj (CenterVue SpA)
  • Nikon Corporation (Optos PLC)
  • Optomed PLC
  • Epipole Ltd.
  • Nidek Co., Ltd.
  • Eyenuk, Inc.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free